Celleraterx
Payments companies reported to CMS as associated with Celleraterx. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Celleraterx, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Celleraterx
These are the largest totals companies reported as associated with Celleraterx. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Christopher Bibbo | Stevens Point, WI | Orthopaedic Surgery | $128,661.37 |
| John Ellington | Charlotte, NC | Orthopaedic Surgery | $92,114.95 |
| William Carpenter | Nashville, TN | Adult Reconstructive Orthopaedic Surgery | $85,875.55 |
| Amit Dwivedi | Louisville, KY | Vascular Surgery | $84,945.43 |
| Frank Buttacavoli | San Antonio, TX | Orthopaedic Surgery | $82,651.97 |
| Samir Awad | Houston, TX | Surgical Critical Care | $81,594.46 |
| Bryan Hanypsiak | Naples, FL | Orthopaedic Surgery | $76,130.95 |
| Walter Lowe | Houston, TX | Sports Medicine (Orthopaedic Surgery) | $75,367.28 |
| Donald Hohman | Dallas, TX | Adult Reconstructive Orthopaedic Surgery | $45,779.52 |
| Merritt Kinon | Bronx, NY | Neurological Surgery | $39,689.29 |
Prescribed Celleraterx?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.